A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With InhibitorMohammad Faranoush, Majid Naderi, Behrouz Vaziri et al.|Clinical and Applied Thrombosis/Hemostasis|2014Cited by 22